复星医药(02196) - 致登记股东之通知信函及回条
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.* 上 海 復 星 醫 藥( 集 團 )股 份 有 限 公 司 (a joint stock company incorporated in the People's Republic of China with limited liability) (於中華人民共和國註冊成立的股份有限公司) (Stock Code 股份代號:02196) NOTIFICATION LETTER 通知信函 4 February 2026 Dear Registered Shareholders. Shanghai Fosun Pharmaceutical (Group) Co., Ltd.* (the "Company") — Notice of publication of circular of the 2026 first extraordinary general meeting and 2026 first H shareholders' class meeting, notice of the 2026 first ex ...